<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="doi: 10.1186/s10194-019-1046-4 : Review Article Differences in treatment response between" exact="migraine" post="with aura and migraine without aura: lessons from clinical"/>
 <result pre="Article Differences in treatment response between migraine with aura and" exact="migraine" post="without aura: lessons from clinical practice and RCTs http://orcid.org/0000-0002-9417-2481"/>
 <result pre="disability worldwide, yet our understanding of the basis mechanisms of" exact="migraine" post="remains incomplete. About a third of migraine patients have"/>
 <result pre="basis mechanisms of migraine remains incomplete. About a third of" exact="migraine" post="patients have attacks with aura, consisting of transient neurological"/>
 <result pre="mechanisms of migraine. Several observations point toward important differences between" exact="migraine" post="with and without aura. Compared with migraine without aura,"/>
 <result pre="important differences between migraine with and without aura. Compared with" exact="migraine" post="without aura, migraine with aura has different heritability, greater"/>
 <result pre="migraine with and without aura. Compared with migraine without aura," exact="migraine" post="with aura has different heritability, greater association with different"/>
 <result pre="by imaging studies. A number of studies also indicate that" exact="migraine" post="with aura may respond differently to acute and preventive"/>
 <result pre="respond differently to acute and preventive therapies as compared to" exact="migraine" post="without aura. The purpose of this review is to"/>
 <result pre="and to discuss the possibility of different therapeutic strategies for" exact="migraine" post="with vs. without aura. Keywords Migraine Migraine aura Migraine"/>
 <result pre="dawn of medicine with the first accounts of attacks of" exact="migraine" post="with aura dating back more than two millennia ["/>
 <result pre="dating back more than two millennia [ 5]. Still today," exact="migraine" post="aura is both an alarming symptom to patients and"/>
 <result pre="clinicians and scientists. Several observations point toward important differences between" exact="migraine" post="with and without aura. Migraine with and without aura"/>
 <result pre="of ischemic stroke, whereas no increased risk is associated with" exact="migraine" post="without aura [ 7, 8]. A number of other"/>
 <result pre="8]. A number of other disorders are also associated with" exact="migraine" post="with aura, but not with migraine without aura ["/>
 <result pre="are also associated with migraine with aura, but not with" exact="migraine" post="without aura [ 9]. Imaging studies suggest that structural"/>
 <result pre="that structural brain changes are more prevalent in those with" exact="migraine" post="than in controls, and some of these changes are"/>
 <result pre="controls, and some of these changes are most pronounced in" exact="migraine" post="with aura [ 10]. During attacks, cerebral blood flow"/>
 <result pre="10]. During attacks, cerebral blood flow changes may differ between" exact="migraine" post="with and without aura [ 11, 12]. Whether migraine"/>
 <result pre="between migraine with and without aura [ 11, 12]. Whether" exact="migraine" post="with aura represents a distinct disorder or is simply"/>
 <result pre="disorder or is simply a part of the spectrum of" exact="migraine" post="remains an open question. Regardless of the answer to"/>
 <result pre="therapies, and also in the efficacy of preventive approaches for" exact="migraine" post="with vs. without aura. What is migraine aura? Up"/>
 <result pre="preventive approaches for migraine with vs. without aura. What is" exact="migraine" post="aura? Up to 1/3 of migraine patients experiences aura"/>
 <result pre="without aura. What is migraine aura? Up to 1/3 of" exact="migraine" post="patients experiences aura [ 13]; reversible transient focal neurological"/>
 <result pre="the cortex or brainstem [ 14]. The diagnostic criteria for" exact="migraine" post="with aura are listed in Table 1. Table 1"/>
 <result pre="are listed in Table 1. Table 1 ICHD-3 criteria for" exact="migraine" post="with aura [ 14] A. At least two attacks"/>
 <result pre="symptom; dysarthria may or may not be Among patients with" exact="migraine" post="with aura, 99% of patients report visual symptoms in"/>
 <result pre="Clinical observations suggest a high degree of clinical variability in" exact="migraine" post="aura both between patients [ 16] and from one"/>
 <result pre="one attack to the next [ 17]. Most patients with" exact="migraine" post="with aura also have migraine attacks without aura. In"/>
 <result pre="[ 17]. Most patients with migraine with aura also have" exact="migraine" post="attacks without aura. In patients with attacks with and"/>
 <result pre="brain tissue. Fig. 1 Typical propagation pattern of a visual" exact="migraine" post="aura. The figure depicts the right visual hemifield and"/>
 <result pre="figure depicts the right visual hemifield and the travelling visual" exact="migraine" post="aura, with the numbers indicating the time passed (in"/>
 <result pre="The temporal and spatial characteristics of the spread of the" exact="migraine" post="visual aura are similar to those that would be"/>
 <result pre="clinical symptoms and therefore considered a likely mechanisms of the" exact="migraine" post="visual aura [ 25]. Potential differences in disease mechanisms"/>
 <result pre="visual aura [ 25]. Potential differences in disease mechanisms in" exact="migraine" post="with and without aura Cortical spreading depression The migraine"/>
 <result pre="in migraine with and without aura Cortical spreading depression The" exact="migraine" post="aura served to differ between migraines two major clinical"/>
 <result pre="blood-brain barrier remained intact during the headache phase of spontaneous" exact="migraine" post="with aura [ 29] and attacks without aura ["/>
 <result pre="attacks without aura [ 30] as well as during GTN-induced" exact="migraine" post="[ 31]. Most migraine patients do not have auras,"/>
 <result pre="30] as well as during GTN-induced migraine [ 31]. Most" exact="migraine" post="patients do not have auras, and auras may also"/>
 <result pre="tonabasat [ 32] that auras may be reduced without reducing" exact="migraine" post="headache without aura speak against subclinical CSD happening silently"/>
 <result pre="aura. Imaging Two metaanalyses have looked at the relationship between" exact="migraine" post="and white matter abnormalities on MRI. Based on seven"/>
 <result pre="Based on seven studies, it was found that patients with" exact="migraine" post="has an four times increased risk for WMA, OR"/>
 <result pre="in controls. Compared to controls, the risk was higher in" exact="migraine" post="with aura, OR 1.68 (95% CI 1.07–2.65), but not"/>
 <result pre="with aura, OR 1.68 (95% CI 1.07–2.65), but not in" exact="migraine" post="without aura OR 1.34; 95% CI 0.96–1.87), without any"/>
 <result pre="aura. The risk for infarct-like lesions did not differ between" exact="migraine" post="with aura and controls, or between migraine without aura"/>
 <result pre="not differ between migraine with aura and controls, or between" exact="migraine" post="without aura and controls. The risk in migraine with"/>
 <result pre="or between migraine without aura and controls. The risk in" exact="migraine" post="with aura was, however, greater than in migraine without"/>
 <result pre="risk in migraine with aura was, however, greater than in" exact="migraine" post="without aura OR 1.44 (95% CI 1.02–2.03), based on"/>
 <result pre="imaging biomarkers that may potentially be used in decisions regarding" exact="migraine" post="diagnoses, treatment and prognostication. In patients with migraine with"/>
 <result pre="decisions regarding migraine diagnoses, treatment and prognostication. In patients with" exact="migraine" post="with aura different pattern of cortical thickness was observed"/>
 <result pre="also exist outside the brain, as it was reported that" exact="migraine" post="with, but not without, aura was associated with foveal"/>
 <result pre="and cerebrovascular disease The available data of the association between" exact="migraine" post="and ischemic stroke have been examined in four pooled"/>
 <result pre="The available data of the association between migraine and ischemic" exact="stroke" post="have been examined in four pooled meta-analyses [ 9,"/>
 <result pre="stroke. Endothelial dysfunction Endothelial dysfunction might play a role connecting" exact="migraine" post="and stroke. Endothelial dysfunction in the broadest sense would"/>
 <result pre="coagulation, inflammation and oxidative stress [ 42]. In total 125" exact="migraine" post="patients were included, evenly divided between migraine with and"/>
 <result pre="In total 125 migraine patients were included, evenly divided between" exact="migraine" post="with and without aura. The authors reported a robust"/>
 <result pre="number of biomarkers of endothelial activation and migraine, especially for" exact="migraine" post="with aura. Vasoconstriction and the use of anti-migraine-drugs Some"/>
 <result pre="increased risk of vascular events [ 43]. Ergot alkaloids in" exact="migraine" post="patients has not been statistically verified as a stroke"/>
 <result pre="in migraine patients has not been statistically verified as a" exact="stroke" post="risk factor but high ergotamine consumption is possibly associated"/>
 <result pre="it must be fairly limited [ 45]. Patent foramen ovale," exact="migraine" post="and aura Patent foramen ovale (PFO) is a common"/>
 <result pre="congenital cardiac defect that may serve as right-to-left shunt for" exact="paradoxical embolism" post="and cause ischemic stroke, especially in the young ["/>
 <result pre="especially in the young [ 46]. In patients with cryptogenic" exact="stroke" post="with concomitant migraine, there is a high prevalence of"/>
 <result pre="high prevalence of PFO (79%), and in the group with" exact="migraine" post="with frequent auras an astounding 93% had PFO ["/>
 <result pre="review [ 48] demonstrates that compared to the general population," exact="migraine" post="is associated with a higher prevalence of patent foramen"/>
 <result pre="general population, migraine is associated with a higher prevalence of" exact="patent foramen ovale," post="especially for migraine with aura. As for tonbasat, PFO"/>
 <result pre="with a higher prevalence of patent foramen ovale, especially for" exact="migraine" post="with aura. As for tonbasat, PFO closure does not"/>
 <result pre="As for tonbasat, PFO closure does not seem to benefit" exact="migraine" post="patients in general [ 49, 50], but the patients"/>
 <result pre="[ 51] supporting a causative role for right-to-left shunt in" exact="migraine" post="aura. Interestingly, one study retrospectively examined the effect intensified"/>
 <result pre="and aspirin resulted in fewer patients (12.2%) reported aura or" exact="migraine" post="with aura or aura compared to aspirin alone (42.3%)"/>
 <result pre="with aspirin alone, resulted in a lower monthly frequency of" exact="migraine" post="attacks over 3 months, but no difference between the two"/>
 <result pre="no difference between the two groups regarding the type of" exact="migraine" post="(aura vs no aura) [ 53]. Psychiatric and cognitive"/>
 <result pre="no aura) [ 53]. Psychiatric and cognitive symptoms associated with" exact="migraine" post="with aura In a large population-based study, depression and"/>
 <result pre="In a large population-based study, depression and depression with comorbid" exact="anxiety disorder" post="were more likely in women with MA than in"/>
 <result pre="needs validation. Some, reversible, cognitive impairment may be reported during" exact="migraine" post="attacks [ 55]. A study evaluated cognitive functions and"/>
 <result pre="functions and psychological symptoms in MO and MA, and although" exact="migraine" post="patients in some aspects differed from controls (lower scores"/>
 <result pre="differences emerged between MA and MO [ 56]. Treatment of" exact="migraine" post="with aura Current guidelines recommend that the same treatment"/>
 <result pre="Current guidelines recommend that the same treatment be used in" exact="migraine" post="with and without aura. This is not surprising because"/>
 <result pre="surprising because almost all studies of both acute and preventative" exact="migraine" post="treatments are based on mixed populations of patients that"/>
 <result pre="based on mixed populations of patients that include those with" exact="migraine" post="with aura and/or without aura, and the treatment effect"/>
 <result pre="this diagnosis or attack subtype is rarely reported. Targeting the" exact="migraine" post="aura The aura is transient in nature, and acute"/>
 <result pre="midazolam as an active control. In the 18 subjects with" exact="migraine" post="with prolonged aura completing the study, ketamine reduced the"/>
 <result pre="[ 59]. The usefulness of ketamine for aura-treatment in classical" exact="migraine" post="aura remains to be established. Based on clinical experience"/>
 <result pre="be established. Based on clinical experience and the assumption that" exact="migraine" post="is associated with defective platelets [ 60], aspirin have"/>
 <result pre="with defective platelets [ 60], aspirin have been tested for" exact="migraine" post="aura prophylaxis. In an observational case series of 49"/>
 <result pre="prophylaxis. In an observational case series of 49 patients with" exact="migraine" post="given aspirin 80 mg daily, the aura frequency was reduced"/>
 <result pre="(48%) [ 61]. Another, retrospective study of 203 patients with" exact="migraine" post="with aura, out of whom 95 (46.8%) used acetylsalicylic"/>
 <result pre="well-tolerated, the use of daily aspirin prophylaxis in patients with" exact="migraine" post="aura should be studied further, preferably in a larger"/>
 <result pre="A small open-label trial of levetiracetam included 16 patients with" exact="migraine" post="with aura, and led to reduction in monthly attacks,"/>
 <result pre="tree leaves has been tested for the prophylactic treatment of" exact="migraine" post="with aura (MA). In open-label study in 50 women"/>
 <result pre="aura (MA). In open-label study in 50 women suffering from" exact="migraine" post="with typical aura, or migraine aura without headache the"/>
 <result pre="in 50 women suffering from migraine with typical aura, or" exact="migraine" post="aura without headache the compound lead to a reduced"/>
 <result pre="in a subsequent open-label study [ 66]. Acute treatment of" exact="migraine" post="headache in migraine with aura Triptans Previous studies indicated"/>
 <result pre="open-label study [ 66]. Acute treatment of migraine headache in" exact="migraine" post="with aura Triptans Previous studies indicated that triptans, specifically"/>
 <result pre="and zolmitriptan [ 67– 69], were not effective in relieving" exact="migraine" post="when taken during the aura phase of an attack."/>
 <result pre="relief at one hour. Patients who had aura with their" exact="migraine" post="and those without aura responded similarly to sumatriptan with"/>
 <result pre="three attacks, as soon as they were aware of a" exact="migraine" post="with aura. Sumatriptan reduced the severity of the first"/>
 <result pre="migraine with aura. Sumatriptan reduced the severity of the first" exact="migraine" post="attack (sumatriptan 63% vs. 33% placebo), but the severity"/>
 <result pre="post-hoc comparison of the efficacy of acute treatment in individual" exact="migraine" post="attacks with aura vs. without aura, and for sumatriptan"/>
 <result pre="indicates that sumatriptan is less effective as acute therapy for" exact="migraine" post="attacks with aura compared to attacks without aura. Different"/>
 <result pre="with aura compared to attacks without aura. Different responses of" exact="migraine" post="with vs. without aura to acute therapies may provide"/>
 <result pre="without aura to acute therapies may provide insight into underlying" exact="migraine" post="mechanisms and influence the choice of acute therapies for"/>
 <result pre="influence the choice of acute therapies for different types of" exact="migraine" post="attacks. Transcranial magnetic simulation and other treatments Transcranial magnetic"/>
 <result pre="is a non-invasive procedure designed for the acute treatment of" exact="migraine" post="with aura, based on the principle that a single"/>
 <result pre="transcranial magnetic stimulation interrupt the wave of CSD during a" exact="migraine" post="aura. In a randomized, sham-controlled trial including 164 patients,"/>
 <result pre="n = 14) reported no difference between sTMS and sham for" exact="migraine" post="attacks or migraine days during 8 week trial, but did"/>
 <result pre="no difference between sTMS and sham for migraine attacks or" exact="migraine" post="days during 8 week trial, but did not evaluate aura"/>
 <result pre="on 5 studies concluded that sTMS may be effective for" exact="migraine" post="with aura, but found no effect of sTMS in"/>
 <result pre="with aura, but found no effect of sTMS in chronic" exact="migraine" post="[ 83]. Blinding is an issue in all these"/>
 <result pre="but randomized, placebo-controlled, double blind study of dipyrone (Metamizol) in" exact="migraine" post="with and without aura, the authors reported more pronounced"/>
 <result pre="pain and associated symptoms after placebo administration in patients with" exact="migraine" post="with aura and migraine without aura. After placebo administration,"/>
 <result pre="after placebo administration in patients with migraine with aura and" exact="migraine" post="without aura. After placebo administration, reduction of symptom intensity"/>
 <result pre="symptom intensity (pain, nausea, photophobia, and phonophobia) in patients with" exact="migraine" post="without aura was significantly greater than that observed in"/>
 <result pre="aura was significantly greater than that observed in patients with" exact="migraine" post="with aura, and the authors suggest that future studies"/>
 <result pre="of aura [ 85]. If the placebo rate differs between" exact="migraine" post="with and without aura, studies reporting therapeutic gains and"/>
 <result pre="86]. The effect of magnesium was tested in patients with" exact="migraine" post="without aura and migraine with aura in a randomized,"/>
 <result pre="magnesium was tested in patients with migraine without aura and" exact="migraine" post="with aura in a randomized, double-blind, placebo-controlled study. In"/>
 <result pre="await replication in larger studies. Preventive therapy Preventive treatment for" exact="migraine" post="with aura has historically been for the most part"/>
 <result pre="historically been for the most part similar to treatment for" exact="migraine" post="without aura, and most studies examining preventive migraine treatment"/>
 <result pre="treatment for migraine without aura, and most studies examining preventive" exact="migraine" post="treatment have been done in mixed populations of MA"/>
 <result pre="and MO. A systematic review with meta-analysis of preventive pharmacologic" exact="migraine" post="treatments found that no trials directly compared drug effects"/>
 <result pre="animal studies chronic treatment with a number of widely prescribed" exact="migraine" post="prophylactic drugs (topiramate, valproate, propranolol, amitriptyline, and methysergide) suppressed"/>
 <result pre="suggesting that CSD in rodents is a translational model for" exact="migraine" post="prophylaxis [ 90]. In rats lamotrigine and valproate also"/>
 <result pre="role in headache, it might be expected that patients with" exact="migraine" post="with aura are more likely to respond to prophylaxis"/>
 <result pre="treatment of chronic migraine. In patients using OnabotulinumtoxinA for preventive" exact="migraine" post="treatment, some authors found that aura predict a more"/>
 <result pre="92], whereas others did not [ 93]. Glutamatergic targets for" exact="migraine" post="with aura The link between glutamate and migraine includes"/>
 <result pre="targets for migraine with aura The link between glutamate and" exact="migraine" post="includes increased levels of glutamate in migraine patients, genetics"/>
 <result pre="between glutamate and migraine includes increased levels of glutamate in" exact="migraine" post="patients, genetics suggesting aberrant glutamate signaling in migraine, and"/>
 <result pre="and in a randomized, double-blind, placebo-controlled trial in patients with" exact="migraine" post="without aura, memantine led to an significant reduction in"/>
 <result pre="the proposed mode of action, memantine should also work in" exact="migraine" post="with aura. In a prospective, open-label trial of 127"/>
 <result pre="patients, 81 patients 74.3% had at least one episode of" exact="migraine" post="with aura during baseline, Memantine was effective, but detailed"/>
 <result pre="95]. Another retrospective study also found mementine effective in both" exact="migraine" post="with and without aura. Out of 20 patients with"/>
 <result pre="migraine with and without aura. Out of 20 patients with" exact="migraine" post="with aura, 16 reported that it reduced the frequency"/>
 <result pre="a larger open-label study of lamotrigine examined the prevention of" exact="migraine" post="aura and reported that more than 75% of patients"/>
 <result pre="of aura symptoms experienced a significant reduction of frequency of" exact="migraine" post="attacks. The authors suggested a potential role of aura-like"/>
 <result pre="trigger for trigeminal vascular activation, and subsequently the development of" exact="migraine" post="headaches [ 98]. Another open-label study examined whether lamotrigine"/>
 <result pre="lamotrigine could cause a &amp;gt; 50% reduction in the mean frequency of" exact="migraine" post="auras. Response was considered as excellent (&amp;gt; 75% reduction) in"/>
 <result pre="significant effect [ 100]. In a separate RCT, focused on" exact="migraine" post="with aura, tonabasat was found to prevent attacks of"/>
 <result pre="migraine with aura, tonabasat was found to prevent attacks of" exact="migraine" post="with aura but not those without aura [ 32],"/>
 <result pre="32], suggesting that tonabasat could be a selective drug for" exact="migraine" post="with aura. Topiramate has been shown to inhibit cortical"/>
 <result pre="tended to be somewhat more pronounced than the reduction in" exact="migraine" post="headaches [ 103]. Another study randomized 213 subjects from"/>
 <result pre="[ 104]. Seventy-five (35.5%) subjects in the ITT population had" exact="migraine" post="with aura. The change in mean monthly migraine frequency"/>
 <result pre="population had migraine with aura. The change in mean monthly" exact="migraine" post="frequency was not different between topiramate and placebo. In"/>
 <result pre="is a non-invasive procedure designed for the acute treatment of" exact="migraine" post="with aura, based on the principle that a single"/>
 <result pre="transcranial magnetic stimulation interrupt the wave of CSD during a" exact="migraine" post="aura. In a randomized, sham-controlled trial including 164 patients,"/>
 <result pre="n = 14) reported no difference between sTMS and sham for" exact="migraine" post="attacks or migraine days during 8 week trial, but did"/>
 <result pre="no difference between sTMS and sham for migraine attacks or" exact="migraine" post="days during 8 week trial, but did not evaluate aura"/>
 <result pre="on 5 studies concluded that sTMS may be effective for" exact="migraine" post="with aura, but found no effect of sTMS in"/>
 <result pre="with aura, but found no effect of sTMS in chronic" exact="migraine" post="[ 83]. Blinding is an issue in all these"/>
 <result pre="has not been described. Implications for future trials Patients with" exact="migraine" post="with aura, may have attacks with and without aura"/>
 <result pre="without aura and most had more than one subtype of" exact="migraine" post="with aura [ 106]. Even though few patients report"/>
 <result pre="subcommittee [ 107]. The trials of tonerbasat showed efficacy in" exact="migraine" post="with aura, but not in migraine without aura, suggesting"/>
 <result pre="tonerbasat showed efficacy in migraine with aura, but not in" exact="migraine" post="without aura, suggesting that migraine with and without aura"/>
 <result pre="with aura, but not in migraine without aura, suggesting that" exact="migraine" post="with and without aura should be studied separately ["/>
 <result pre="without aura should be studied separately [ 108]. Trials of" exact="migraine" post="prophylactic drugs generally focus on reduction in the number"/>
 <result pre="prophylactic drugs generally focus on reduction in the number of" exact="migraine" post="days as the key efficacy parameter, and little attention"/>
 <result pre="that some treatments may have different efficacy in attacks of" exact="migraine" post="with aura vs. without aura. It is an important"/>
 <result pre="It is an important confounder that many patients diagnosed with" exact="migraine" post="with aura occasionally have attacks of migraine without aura"/>
 <result pre="patients diagnosed with migraine with aura occasionally have attacks of" exact="migraine" post="without aura – and vice versa. It is unresolved"/>
 <result pre="employ different treatment strategies based on a previous history of" exact="migraine" post="with versus without aura, or based on the presence"/>
 <result pre="may be an important step to personalized medicine in acute" exact="migraine" post="treatment. Publisher’s Note Springer Nature remains neutral with regard"/>
 <result pre="Press 6. Russell MB et al. Migraine without aura and" exact="migraine" post="with aura are distinct clinical entities: a study of"/>
 <result pre="Stang PE et al. Headache, cerebrovascular symptoms, and stroke: the" exact="atherosclerosis" post="risk in communities study Neurology 2005 64 9 1573"/>
 <result pre="Kurth T et al. Migraine, headache, and the risk of" exact="stroke" post="in women: a prospective study Neurology 2005 64 6"/>
 <result pre="1268 10.1212/WNL.0b013e3182a6cb32 23986301 11. Olesen J et al. The common" exact="migraine" post="attack may not be initiated by cerebral ischaemia Lancet"/>
 <result pre="and topography of cerebral blood flow, aura, and headache during" exact="migraine" post="attacks Ann Neurol 1990 28 6 791 798 10.1002/ana.410280610"/>
 <result pre="MB et al. Prevalence and sex-ratio of the subtypes of" exact="migraine" post="Int J Epidemiol 1995 24 3 612 618 10.1093/ije/24.3.612"/>
 <result pre="PJ Charles AC Variability of clinical features in attacks of" exact="migraine" post="with aura Cephalalgia : an international journal of headache"/>
 <result pre="Viana M et al. Variability of the characteristics of a" exact="migraine" post="attack within patients Cephalalgia : an international journal of"/>
 <result pre="18. Hauge AW Kirchmann M Olesen J Trigger factors in" exact="migraine" post="with aura Cephalalgia : an international journal of headache"/>
 <result pre="2049 10.1212/WNL.0b013e3182749eed 23115208 20. Queiroz LP et al. Characteristics of" exact="migraine" post="visual aura in southern Brazil and northern USA Cephalalgia"/>
 <result pre="21. Russell MB Olesen J A nosographic analysis of the" exact="migraine" post="aura in a general population Brain 1996 119 Pt"/>
 <result pre="K Patterns of cerebral integration indicated by the scotomas of" exact="migraine" post="Arch Neurol Psychiatr 1941 46 2 331 339 10.1001/archneurpsyc.1941.02280200137007"/>
 <result pre="6 359 390 10.1152/jn.1944.7.6.359 25. Lauritzen M Pathophysiology of the" exact="migraine" post="aura. The spreading depression theory Brain 1994 117 Pt"/>
 <result pre="al. Intrinsic brain activity triggers trigeminal meningeal afferents in a" exact="migraine" post="model Nat Med 2002 8 2 136 142 10.1038/nm0202-136"/>
 <result pre="brainstem perfusion, but no blood-brain barrier disruption, during attacks of" exact="migraine" post="with aura Brain 2017 140 6 1633 1642 10.1093/brain/awx089"/>
 <result pre="FM et al. Intact blood-brain barrier during spontaneous attacks of" exact="migraine" post="without aura: a 3T DCE-MRI study Eur J Neurol"/>
 <result pre="integrity of the blood-brain barrier for 11C-dihydroergotamine during glyceryl trinitrate-induced" exact="migraine" post="Brain : a journal of neurology 2016 139 Pt"/>
 <result pre="27234268 32. Hauge AW et al. Effects of tonabersat on" exact="migraine" post="with aura: a randomised, double-blind, placebo-controlled crossover study The"/>
 <result pre="Chang MY et al. Foveal and Peripapillary vascular decrement in" exact="migraine" post="with Aura demonstrated by optical coherence tomography angiography Invest"/>
 <result pre="10.1007/s10072-016-2746-z 39. Spector JT et al. Migraine headache and ischemic" exact="stroke" post="risk: an updated meta-analysis Am J Med 2010 123"/>
 <result pre="10.1016/j.amjmed.2009.12.021 20493462 40. Etminan M et al. Risk of ischaemic" exact="stroke" post="in people with migraine: systematic review and meta-analysis of"/>
 <result pre="GC et al. Triptans in migraine: the risks of stroke," exact="cardiovascular disease," post="and death in practice Neurology 2004 62 4 563"/>
 <result pre="131 10.1177/0333102414550416 25246519 46. Lechat P et al. Prevalence of" exact="patent foramen ovale" post="in patients with stroke N Engl J Med 1988"/>
 <result pre="et al. Prevalence of patent foramen ovale in patients with" exact="stroke" post="N Engl J Med 1988 318 18 1148 1152"/>
 <result pre="BH et al (2018) Frequency of patent foramen Ovale and" exact="migraine" post="in patients with cryptogenic stroke. Stroke 48. Lip PZ"/>
 <result pre="Stroke 48. Lip PZ Lip GY Patent foramen ovale and" exact="migraine" post="attacks: a systematic review Am J Med 2014 127"/>
 <result pre="10.1016/j.jacc.2017.09.1105 29191325 50. Mattle HP et al. Percutaneous closure of" exact="patent foramen ovale" post="in migraine with aura, a randomized controlled trial Eur"/>
 <result pre="HP et al. Percutaneous closure of patent foramen ovale in" exact="migraine" post="with aura, a randomized controlled trial Eur Heart J"/>
 <result pre="51. Nozari A et al. Microemboli may link spreading depression," exact="migraine" post="aura, and patent foramen ovale Ann Neurol 2010 67"/>
 <result pre="et al. Microemboli may link spreading depression, migraine aura, and" exact="patent foramen ovale" post="Ann Neurol 2010 67 2 221 229 10.1002/ana.21871 20225282"/>
 <result pre="229 10.1002/ana.21871 20225282 52. Wilmshurst PT et al. Clopidogrel reduces" exact="migraine" post="with aura after transcatheter closure of persistent foramen ovale"/>
 <result pre="al. Effect of Clopidogrel and aspirin vs aspirin alone on" exact="migraine" post="headaches after Transcatheter atrial septal defect closure: the CANOA"/>
 <result pre="and aspirin vs aspirin alone on migraine headaches after Transcatheter" exact="atrial septal defect" post="closure: the CANOA randomized clinical trial JAMA : the"/>
 <result pre="al. Migraine with and without aura: association with depression and" exact="anxiety disorder" post="in a population-based study. The HUNT study Cephalalgia :"/>
 <result pre="R Oliveira AG Martins IP Assessment of cognitive dysfunction during" exact="migraine" post="attacks: a systematic review J Neurol 2015 262 3"/>
 <result pre="Charles A Glutamate and its receptors as therapeutic targets for" exact="migraine" post="Neurotherapeutics : the journal of the American Society for"/>
 <result pre="58. Kaube H et al. Aura in some patients with" exact="familial hemiplegic migraine" post="can be stopped by intranasal ketamine Neurology 2000 55"/>
 <result pre="H et al. Aura in some patients with familial hemiplegic" exact="migraine" post="can be stopped by intranasal ketamine Neurology 2000 55"/>
 <result pre="et al. A randomized controlled trial of intranasal ketamine in" exact="migraine" post="with prolonged aura Neurology 2013 80 7 642 647"/>
 <result pre="10.1016/S0140-6736(82)92373-X 6123003 61. Turk WE et al. Aspirin prophylaxis for" exact="migraine" post="with Aura: an observational case series Eur Neurol 2017"/>
 <result pre="62. Anoaica MB Anoaica PG Popescu F Acetylsalicylic acid in" exact="migraine" post="with aura prevention - a retrospective study Curr Health"/>
 <result pre="63. Brighina F et al. Levetiracetam in the prophylaxis of" exact="migraine" post="with aura: a 6-month open-label study Clin Neuropharmacol 2006"/>
 <result pre="al. Acid-sensing ion channel 1: a novel therapeutic target for" exact="migraine" post="with aura Ann Neurol 2012 72 4 559 563"/>
 <result pre="et al. Efficacy of Ginkgolide B in the prophylaxis of" exact="migraine" post="with aura Neurological sciences : official journal of the"/>
 <result pre="The efficacy of ginkgolide B in the acute treatment of" exact="migraine" post="aura: an open preliminary trial Neurological sciences : official"/>
 <result pre="10.1007/s10072-013-1413-x 67. Bates, D., et al., Subcutaneous sumatriptan during the" exact="migraine" post="aura . Sumatriptan Aura Study Group Neurology, 1994. 44(9):"/>
 <result pre="Dowson A Can oral 311C90, a novel 5-HT1D agonist, prevent" exact="migraine" post="headache when taken during an aura? Eur Neurol 1996"/>
 <result pre="No effect of eletriptan administration during the aura phase of" exact="migraine" post="European journal of neurology : the official journal of"/>
 <result pre="the efficacy of sumatriptan therapy during the aura phase of" exact="migraine" post="Headache 2009 49 7 1001 1004 10.1111/j.1526-4610.2009.01429.x 19438735 71."/>
 <result pre="Mathew N Nett R Triptans in the treatment of basilar" exact="migraine" post="and migraine with prolonged aura Headache 2001 41 10"/>
 <result pre="Nett R Triptans in the treatment of basilar migraine and" exact="migraine" post="with prolonged aura Headache 2001 41 10 981 984"/>
 <result pre="10.1046/j.1526-4610.2001.01192.x 11903526 72. Artto V et al. Treatment of hemiplegic" exact="migraine" post="with triptans Eur J Neurol 2007 14 9 1053"/>
 <result pre="14 9 1053 1056 10.1111/j.1468-1331.2007.01900.x 17718700 73. Subcutaneous_Sumatriptan_International_Study_Group, Treatment of" exact="migraine" post="attacks with sumatriptan. The subcutaneous Sumatriptan international study group"/>
 <result pre="Banerjee M Findley LJ Sumatriptan in the treatment of acute" exact="migraine" post="with aura Cephalalgia : an international journal of headache"/>
 <result pre="S Moore RA Sumatriptan (subcutaneous route of administration) for acute" exact="migraine" post="attacks in adults Cochrane Database Syst Rev 2012 2"/>
 <result pre="S Moore RA Sumatriptan (oral route of administration) for acute" exact="migraine" post="attacks in adults Cochrane Database Syst Rev 2012 2"/>
 <result pre="S Moore RA Sumatriptan (intranasal route of administration) for acute" exact="migraine" post="attacks in adults Cochrane Database Syst Rev 2012 2"/>
 <result pre="JM Goadsby PJ Charles A Reduced efficacy of sumatriptan in" exact="migraine" post="with aura vs without aura Neurology 2015 84 18"/>
 <result pre="et al. Single-pulse transcranial magnetic stimulation for acute treatment of" exact="migraine" post="with aura: a randomised, double-blind, parallel-group, sham-controlled trial Lancet"/>
 <result pre="Low-frequency rTMS of the vertex in the prophylactic treatment of" exact="migraine" post="Cephalalgia : an international journal of headache 2010 30"/>
 <result pre="ME et al. Intravenous dipyrone in the acute treatment of" exact="migraine" post="without aura and migraine with aura: a randomized, double"/>
 <result pre="dipyrone in the acute treatment of migraine without aura and" exact="migraine" post="with aura: a randomized, double blind, placebo controlled study"/>
 <result pre="12390611 85. Bigal ME et al. Migraine with aura versus" exact="migraine" post="without aura: pain intensity and associated symptom intensities after"/>
 <result pre="et al. Intravenous magnesium sulphate in the acute treatment of" exact="migraine" post="without aura and migraine with aura. A randomized, double-blind,"/>
 <result pre="sulphate in the acute treatment of migraine without aura and" exact="migraine" post="with aura. A randomized, double-blind, placebo-controlled study Cephalalgia :"/>
 <result pre="89. Shamliyan TA et al. Preventive pharmacologic treatments for episodic" exact="migraine" post="in adults 2013 90. Ayata C et al. Suppression"/>
 <result pre="Ayata C et al. Suppression of cortical spreading depression in" exact="migraine" post="prophylaxis Ann Neurol 2006 59 4 652 661 10.1002/ana.20778"/>
 <result pre="PM Alvarez MV Jones L Headache direction and aura predict" exact="migraine" post="responsiveness to rimabotulinumtoxin B Headache 2013 53 1 126"/>
 <result pre="93. Jakubowski M et al. Exploding vs. imploding headache in" exact="migraine" post="prophylaxis with botulinum toxin a Pain 2006 125 3"/>
 <result pre="94. Noruzzadeh R et al. Memantine for prophylactic treatment of" exact="migraine" post="without Aura: a randomized double-blind placebo-controlled study Headache 2016"/>
 <result pre="efficacy of Memantine as add on therapy in patients with" exact="migraine" post="Iranian journal of pharmaceutical research : IJPR 2017 16"/>
 <result pre="Lampl C et al. Lamotrigine in the prophylactic treatment of" exact="migraine" post="aura--a pilot study Cephalalgia : an international journal of"/>
 <result pre="63 10.1111/j.1468-2982.1999.1901058.x 10099861 98. Lampl C et al. Lamotrigine reduces" exact="migraine" post="aura and migraine attacks in patients with migraine with"/>
 <result pre="98. Lampl C et al. Lamotrigine reduces migraine aura and" exact="migraine" post="attacks in patients with migraine with aura J Neurol"/>
 <result pre="Lamotrigine reduces migraine aura and migraine attacks in patients with" exact="migraine" post="with aura J Neurol Neurosurg Psychiatry 2005 76 12"/>
 <result pre="1732 10.1136/jnnp.2005.063750 16291905 99. Pascual J et al. Preventing disturbing" exact="migraine" post="aura with lamotrigine: an open study Headache 2004 44"/>
 <result pre="and safety in two randomized, placebo-controlled, dose-ranging studies of acute" exact="migraine" post="Cephalalgia : an international journal of headache 2009 29"/>
 <result pre="102. Diener HC et al. Cessation versus continuation of 6-month" exact="migraine" post="preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled"/>
 <result pre="and tolerability of topiramate 200 mg/d in the prevention of" exact="migraine" post="with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week"/>
 <result pre="IH et al. Factors associated with favorable outcome of Topiramate" exact="migraine" post="prophylaxis in pediatric patients Journal of clinical neurology 2017"/>
 <result pre="MK et al. Clinical characteristics of 362 patients with familial" exact="migraine" post="with aura Cephalalgia 2004 24 7 564 575 10.1111/j.1468-2982.2003.00718.x"/>
 <result pre="A Olesen J On the methodology of drug trials in" exact="migraine" post="with aura Cephalalgia : an international journal of headache"/>
</results>
